3 min read
Measuring What Can't Be Seen: How PTSD Clinical Trials Prove a Drug Works
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...
May 11-15, 2026 – Boston, MA
Veristat is pleased to attend OCT East Coast 2026, a leading event for clinical operations leaders focused on the realities of trial execution. As protocols grow more complex and timelines compress, success depends on more than activity. It depends on alignment, discipline, and decisions that hold up under pressure.
Our team looks forward to connecting with clinical and operational leaders to discuss how Veristat helps sponsors reduce rework, improve decision speed, and make every dollar of development capital count.
Connect with us to explore how Veristat’s scientific leadership and focused capabilities support confident decisions and efficient progress across clinical and regulatory milestones.
Complete the form on this page to reserve time with our team. We welcome the opportunity to learn about your upcoming programs and explore how Veristat can support your development strategy.
Veristat’s work centers on the capabilities sponsors need most as programs move toward key development and regulatory milestones:
Phase I-II Clinical Development
Biostatistics and Data-Driven Evidence
Together, these capabilities help sponsors move from study design to submission with clarity, reduce rework, and accelerate progress toward patients while preserving development capital.
Meet with us at OCT East Coast
New Brunswick, NJ | May 13-16
3 min read
Apr 27, 2026 Veristat Blog
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...
3 min read
Apr 24, 2026 Veristat Blog
In August 2024, the FDA declined to approve MDMA-assisted therapy for post-traumatic stress disorder. The decision...